abstract |
This invention provides a method of providing estrogen therapy ornsupplementation in a mammal in need thereof, wherein an elevation in prolactin levelsnconcomitant with said estrogenic supplementation is undesirable in said mammal,nwhich comprises administering an effective amount of 8,9-dehydroestrone or anpharmaceutically acceptable salt of its 3-sulfate ester to said mammal. |